A recent study concluded that people who lost more than 20% of their body weight experienced a far greater reduction in symptoms of knee osteoarthritis than those who lost less.
Though a relatively recent discovery, adipose derived stem cells are widely researched across the globe.
Osteoarthritis and rheumatoid arthritis are two very different forms of arthritis. It is important to understand the differences and to receive a correct diagnosis in order to pursue proper treatment.
Mesenchymal stem cells rely on multiple mechanisms for success. Mesenchymal stem cell therapy delivers a functionally diverse cell population
There are multiple symptoms of osteoarthritis and it is important to visit your doctor if you are concerned you may have osteoarthritis.
Personalized Stem Cells founder and CEO, Dr. Bob Harman, reflects on his backpacking trips and his connection to the world of regenerative medicine.
Personalized Stem Cells announces Brazilian authorization for Phase 2 COVID-19 stem cell clinical trial licensed to Sorrento Therapeutics.
Mesenchymal stem cells are multipotent adult stem cells that have multiple modes of action, making them a potential treatment option for a wide array of conditions.
Personalized Stem Cells recently announced the COVID-19 stem cell clinical trial reached the target enrollment of ten patients.
Personalized Stem Cells, Inc. announces additional positive results in COVID-19 FDA approved stem cell clinical trial licensed to Sorrento Therapeutics.